Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Streptococcus suis IgM protease, primarily known as IdeSsuis, is a 124 kDa cysteine protease secreted by the porcine pathogen Streptococcus suis (Seele et al., 2013). Its primary biological function is the highly specific cleavage of porcine IgM between the C2 and C3 domains, which disrupts the classical complement pathway and allows the bacteria to evade the host's early immune response (Seele et al., 2015). This target also encompasses related Streptococcus suis antigens, such as suilysin (Sly), muramidase-released protein (MRP), and surface antigen one (Sao), which are frequently combined in vaccine formulations to enhance protective efficacy (Patent US11607447). These antigens are critical for the development of recombinant subunit vaccines aimed at preventing invasive diseases like meningitis, septicemia, and arthritis in swine. By inducing the production of opsonizing antibodies, these vaccines restore the host's ability to clear the pathogen and reduce the risk of zoonotic transmission to humans. The targeting of these proteins represents a key strategy for improving animal health and reducing antibiotic use in the global swine industry.
Induction of neutralizing and opsonizing antibodies that inhibit the enzymatic activity of the IgM protease and other virulence factors, thereby preventing immune evasion and facilitating bacterial clearance by host phagocytes.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Streptococcus suis IgM protease and related Streptococcus suis antigens.